Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Boxidine inhibits the transformation of 7-dehydrocholesterol to cholesterol & also inhibits sterol absorption.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Boxidine inhibits the transformation of 7-dehydrocholesterol to cholesterol & also inhibits sterol absorption. |
分子量 | 335.36 |
分子式 | C19H20F3NO |
CAS No. | 10355-14-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Boxidine 10355-14-3 10oxo12cisOctadecenoic Acid 10-oxo-12-cis-Octadecenoic Acid 10 oxo 12(Z) Octadecenoic Acid 10oxo12(Z)Octadecenoic Acid 10-keto-12Z-Octadecenoic Acid 10 keto 12Z Octadecenoic Acid 10keto12ZOctadecenoic Acid 10 oxo 12 cis Octadecenoic Acid Inhibitor inhibitor inhibit